Search

11 June 2025 - These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for mucopolysaccharidosis type IVA (MPS IVA) under the Life Saving Drugs Program.

11 June 2025 - These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for mucopolysaccharidosis type I (MPS I) under the Life Saving Drugs Program.

11 June 2025 - These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for mucopolysaccharidosis type II (MPS II) under the Life Saving Drugs Program.

11 June 2025 - These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for mucopolysaccharidosis type VI (MPS VI) under the Life Saving Drugs Program.

3 February 2020 - What’s important to you when it comes to preparing your end-of-life care? Thinking about these things can help make important decisions easier for you and your loved ones.

19 November 2024 - Use this toolkit to spread the word about STIs and encourage safe sex, testing and treatment in the Northern Territory community. This toolkit includes videos, social animations and posters.

28 September 2023 - Consultation on the Roadmap and Implementation Plan for the Million Minds Mental Health Research Mission is now open.

17 February 2023 - Listen to the stories of Judith, Julie, Clare and Merlinda on how early breast cancer screening saved their lives.

17 June 2025 - The documents in this collection aim to help Primary Health Networks (PHNs) who are implementing primary mental health care reform activities. The documents provide clarity in core issues, set out expectations and provide best-practice examples.

24 January 2024 - This strategy aims to reduce the use and harmful effects of ice in Australia.